Denali Therapeutics Inc.
DNLI | NASDAQ
$21.10
+$0.63 (+3.08%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -639.9M | -508.02M | -512.54M | -498.74M | -479.03M | -453.94M | -422.77M | -427.49M | -419.65M | -137.25M | -145.22M | -124.43M | -128.38M | -370.55M | -325.99M | -302.57M | -283.86M | -285.76M | -290.58M | 29.57M | 55.93M | 57.86M |
Depreciation & Amortization | 16.9M | 13.54M | 12.99M | 11.06M | 9.95M | 8.85M | 7.8M | 8.12M | 8.5M | 7.91M | 15.8M | 16.85M | 15.91M | 15.78M | 7.03M | 5.12M | 5.24M | 5.49M | 5.61M | 5.73M | 6.48M | 7.15M |
Stock-Based Compensation | 93.04M | 47.04M | 49.11M | 50.24M | 50.24M | 75.34M | 78.02M | 78.93M | 106.39M | 81.29M | 81.53M | 55.54M | 28.08M | 28.08M | n/a | n/a | n/a | n/a | n/a | n/a | 13.25M | 13.25M |
Other Working Capital | -44.29M | -4.41M | 7.67M | 8.51M | 45.39M | 12.65M | 15.5M | 14.16M | -21.01M | -326.68M | -292.36M | -297.92M | -278.33M | 28.78M | -26.3M | -44.66M | -46.49M | -56.9M | -24.12M | 246.26M | 271.65M | 295.59M |
Other Non-Cash Items | 16.56M | 40.52M | 37.69M | 33.98M | 26.97M | -6.6M | -27.67M | -34.42M | -63.57M | -37.45M | -20.17M | 15.16M | 52.38M | 61.77M | 98.27M | 100.66M | 100.38M | 99.58M | 94M | 84.46M | 60.12M | 47.26M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -51.85M | -5.41M | 149K | 5.69M | 42.26M | 10.81M | 16.94M | 12.23M | -22.53M | -327.31M | -289.93M | -295.12M | -269.67M | 33.51M | -24.03M | -40.75M | -43.7M | -52.57M | -20.41M | 248.27M | 273.77M | 294.88M |
Operating Cash Flow | -565.24M | -412.34M | -412.6M | -397.78M | -349.62M | -365.54M | -347.69M | -362.64M | -390.86M | -412.81M | -357.99M | -332M | -301.68M | -231.41M | -244.72M | -237.55M | -221.94M | -233.26M | -211.39M | 368.02M | 409.54M | 420.4M |
Capital Expenditures | -5.88M | -6.89M | -9.5M | -13.07M | -18.33M | -18.84M | -15.91M | -13.06M | -11.24M | -12.3M | -12.94M | -15.55M | -19.54M | -16.58M | -17.83M | -16.04M | -11.86M | -9.74M | -8.5M | -6.64M | -5.47M | -5.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -849.79M | -426.41M | -441.26M | -362.26M | -412.09M | -533.73M | -1.23B | -1.47B | -1.87B | -2.12B | -1.81B | -1.89B | -1.51B | -1.27B | -1.12B | -859.78M | -1.08B | -1.32B | -1.42B | -1.79B | -1.81B | -1.6B |
Sales Maturities Of Investments | 1.02B | 764.29M | 706.05M | 782.05M | 872.97M | 935.75M | 1.16B | 1.3B | 1.7B | 2.03B | 2.08B | 1.95B | 1.49B | 1.17B | 991.49M | 821.24M | 969.96M | 1.22B | 1.41B | 1.45B | 1.31B | 965.16M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 163.44M | 330.99M | 255.28M | 406.72M | 442.55M | 383.18M | -88.76M | -187.92M | -180.66M | -111.16M | 249.31M | 48.7M | -36.79M | -116.22M | -141.39M | -54.58M | -123.01M | -114.1M | -21.63M | -348.22M | -507.33M | -635.28M |
Debt Repayment | -1.39M | -3.83M | -8.17M | -16.48M | -39.13M | -36.7M | -32.34M | -24.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 399.96M | 200M | n/a | n/a | n/a | n/a | 1.02M | 1.02M | 1.02M | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.75M | 5.75M |
Financial Cash Flow | 644.43M | 412.02M | 189.22M | -7.09M | -24.87M | -19.73M | 484.3M | 493.18M | 514.23M | 516.49M | 17.82M | 312.77M | 315.43M | 310.81M | 310.67M | 16.19M | 14.35M | 16.99M | 19.35M | 23.7M | 446.29M | 442.66M |
Net Cash Flow | 242.62M | 330.68M | 31.9M | 1.86M | 68.06M | -2.1M | 47.85M | -57.38M | -57.29M | -7.56M | -90.94M | 29.4M | -23.12M | -36.82M | -75.43M | -275.94M | -330.59M | -330.37M | -213.67M | 43.51M | 348.5M | 227.78M |
Free Cash Flow | -571.13M | -419.23M | -422.1M | -410.85M | -367.95M | -384.38M | -363.61M | -375.69M | -402.1M | -425.11M | -370.93M | -347.55M | -321.22M | -247.99M | -262.55M | -253.58M | -233.8M | -243M | -219.89M | 361.38M | 404.07M | 415.39M |
Adj. Free Cash Flow | -664.17M | -466.26M | -471.21M | -461.09M | -418.19M | -459.72M | -441.62M | -454.62M | -508.49M | -506.4M | -452.46M | -403.09M | -349.3M | -276.07M | -262.55M | -253.58M | -233.8M | -243M | -219.89M | 361.38M | 390.82M | 402.14M |
Maintenance CapEx | -5.88M | -6.89M | -9.5M | -13.07M | -18.33M | -18.84M | -15.91M | -13.06M | -11.24M | -6.45M | -7.09M | -9.7M | -13.69M | -13.69M | -10.9M | -9.1M | -4.93M | -4.93M | -5.47M | -2.42M | -1.25M | -1.25M |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.85M | -5.85M | -5.85M | -5.85M | -2.89M | -6.93M | -6.93M | -6.93M | -4.81M | -3.03M | -4.22M | -4.22M | -3.77M |
Owner Earnings | -571.13M | -419.23M | -422.1M | -410.85M | -367.95M | -384.38M | -363.61M | -375.69M | -402.1M | -419.26M | -365.08M | -341.7M | -315.37M | -245.09M | -255.62M | -246.65M | -226.86M | -238.19M | -216.86M | 365.6M | 408.29M | 419.15M |
Add to Watchlist
Select watchlists to add or remove DNLI